Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas

[1]  M. Hattori,et al.  The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung. , 2011, Lung cancer.

[2]  I. Wistuba,et al.  Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas. , 2011, American journal of clinical pathology.

[3]  J. Flickinger,et al.  Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas? , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  Yih-Leong Chang,et al.  Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief Report , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Z. Maleki,et al.  Coexistence of gonadoblastoma and dysgerminoma in a dysgenetic gonad on touch preparation: A case report , 2011, Diagnostic cytopathology.

[7]  F. Hirsch,et al.  Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  W. Travis.  Advances in neuroendocrine lung tumors. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  M. Pietanza,et al.  The molecular pathogenesis of small cell lung cancer , 2010, Cancer biology & therapy.

[10]  Z. Maleki.  Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high‐grade basaloid or neuroendocrine morphology , 2010, Diagnostic cytopathology.

[11]  B. Skov,et al.  ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on Survival , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  A. Llombart‐Bosch,et al.  Histological heterogeneity of Ewing’s sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support , 2009, Virchows Archiv.

[13]  Kari Chansky,et al.  The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  W. Travis.  Lung tumours with neuroendocrine differentiation. , 2009, European journal of cancer.

[15]  J. Austin,et al.  The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification , 2009 .

[16]  Takehiko Fujisawa,et al.  Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis , 2006, Modern Pathology.

[17]  C. Papadimitriou,et al.  Immunohistochemical Distinction Between Merkel Cell Carcinoma and Small Cell Carcinoma of the Lung , 2006, The American Journal of dermatopathology.

[18]  A. Nicholson,et al.  CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact , 2005, Journal of Clinical Pathology.

[19]  G. Pelosi,et al.  Typical and Atypical Pulmonary Carcinoid Tumor Overdiagnosed as Small-Cell Carcinoma on Biopsy Specimens: A Major Pitfall in the Management of Lung Cancer Patients , 2005, The American journal of surgical pathology.

[20]  Hisao Asamura,et al.  Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors , 2004, Modern Pathology.

[21]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[22]  G. Pelosi,et al.  CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas , 2004, Virchows Archiv.

[23]  A. Nicholson,et al.  TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. , 2004, Human pathology.

[24]  K. Hiroshima,et al.  Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity. , 2004, The Annals of thoracic surgery.

[25]  Y. Haga,et al.  Genetic alterations in early‐stage pulmonary large cell neuroendocrine carcinoma , 2004, Cancer.

[26]  Y. Nishiwaki,et al.  Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung. , 2003, Lung cancer.

[27]  W. Travis,et al.  The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. , 2003, Human pathology.

[28]  M. Sheppard,et al.  Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens , 2002, The American journal of surgical pathology.

[29]  E. Brambilla,et al.  Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. , 2002, Human pathology.

[30]  A. Marchevsky,et al.  Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms. , 2001, American journal of clinical pathology.

[31]  E. Brambilla,et al.  Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. , 2001, Human pathology.

[32]  N. Leonard,et al.  Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. , 2001, Journal of clinical pathology.

[33]  T. Shields.  Lung cancer: principles and practice, 2nd edition , 2001 .

[34]  M. Zakowski,et al.  Large‐cell neuroendocrine carcinoma of the lung: Proposed criteria for cytologic diagnosis , 2001, Diagnostic cytopathology.

[35]  M. Bongiovanni,et al.  34βE 12 Cytokeratin Immunodetection in the Differential Diagnosis of Small Cell Tumors of Lung , 2000, International journal of surgical pathology.

[36]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[37]  N. Weidner,et al.  Immunohistochemistry of small round-cell tumors. , 2000, Seminars in diagnostic pathology.

[38]  F. Collins,et al.  MEN1 gene mutation analysis of high‐grade neuroendocrine lung carcinoma , 2000, Genes, chromosomes & cancer.

[39]  A. Folpe,et al.  Thyroid Transcription Factor-1 Is Expressed in Extrapulmonary Small Cell Carcinomas but Not in Other Extrapulmonary Neuroendocrine Tumors , 2000, Modern Pathology.

[40]  S. Pilotti,et al.  Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[41]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[42]  S. Jiang,et al.  The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[43]  I. Wistuba,et al.  Genetic changes in the spectrum of neuroendocrine lung tumors , 1999, Cancer.

[44]  W. Travis,et al.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. , 1998, The American journal of surgical pathology.

[45]  W. Travis,et al.  Reproducibility of neuroendocrine lung tumor classification. , 1998, Human pathology.

[46]  F. Collins,et al.  Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. , 1997, Human molecular genetics.

[47]  F. Collins,et al.  Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. , 1997, The Journal of clinical endocrinology and metabolism.

[48]  S. Suster,et al.  Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. , 1997, The American journal of surgical pathology.

[49]  E. Brambilla,et al.  Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. , 1996, The American journal of pathology.

[50]  W. Travis,et al.  Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. , 1996, The American journal of pathology.

[51]  W. Travis,et al.  The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. , 1994, American journal of clinical pathology.

[52]  W. Travis,et al.  A combined small cell and spindle cell carcinoma of the lung. Report of a unique case with immunohistochemical and ultrastructural studies. , 1992, The American journal of surgical pathology.

[53]  A. Fraire,et al.  Prognostic significance of histopathologic subtype and stage in small cell lung cancer. , 1992, Human pathology.

[54]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[55]  W. Travis,et al.  Neuroendocrine Tumors of the Lung With Proposed Criteria for Large‐Cell Neuroendocrine Carcinoma: An Ultrastructural, Immunohistochemical, and Flow Cytometric Study of 35 Cases , 1991, The American journal of surgical pathology.

[56]  R. Steele,et al.  Histopathologic classification of small cell lung cancer changing concepts and terminology , 1988, Cancer.

[57]  A. Mehta,et al.  Peripheral small cell undifferentiated carcinoma of the lung. Clinicopathologic features of 17 cases , 1988, Cancer.

[58]  G. Kalemkerian,et al.  Small cell lung cancer , 2010, Seminars in Respiratory and Critical Care Medicine.

[59]  F. Hirsch,et al.  Morphologic variations of small cell lung cancer: A histopathologic study of pretreatment and posttreatment specimens in 104 patients , 1986, Cancer.

[60]  J. Crissman,et al.  Separation of small-cell from non-small-cell lung cancer. The Southeastern Cancer Study Group pathologists' experience. , 1984, Archives of pathology & laboratory medicine.

[61]  R. Vollmer.  The effect of cell size on the pathologic diagnosis of small and large cell carcinomas of the lung , 1982, Cancer.

[62]  J. Azzopardi.  Oat-cell carcinoma of the bronchus. , 1959, The Journal of pathology and bacteriology.

[63]  L. Tanoue.  Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths , 2012 .

[64]  G. Rossi,et al.  The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. , 2004, The Annals of thoracic surgery.

[65]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[66]  Rochelle L. Garcia,et al.  Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[67]  R. Manne,et al.  Neurofilament immunoreactivity in Merkel-cell tumors: a differentiating feature from small-cell carcinoma. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[68]  E. Ranfaing.  [Neuroendocrine lung tumors]. , 1993, Annales de pathologie.

[69]  E. Brambilla,et al.  Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  H. Kreisman,et al.  Small cell lung cancer presenting as a solitary pulmonary nodule. , 1990, Cancer.